Published in Br J Rheumatol on June 01, 1987
Serum nitric oxide, catalase, superoxide dismutase, and malondialdehyde status in patients with ankylosing spondylitis. Rheumatol Int (2003) 0.91
White blood cell activation in Raynaud's phenomenon of systemic sclerosis and vibration induced white finger syndrome. Ann Rheum Dis (1992) 0.86
The interrelation of glutathione reductase, catalase, glutathione peroxidase, superoxide dismutase, and glucose-6-phosphate in the pathogenesis of rheumatoid arthritis. Clin Rheumatol (2007) 0.85
The effect of anti-TNF agent on oxidation status in patients with ankylosing spondylitis. Clin Rheumatol (2009) 0.80
Effects of D-penicillamine treatment on antioxidant enzymes in rheumatoid arthritis. Br J Rheumatol (1990) 0.75
The Significance of Pleomorphism in Bacteroides Strains. J Bacteriol (1944) 12.62
The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum (1996) 6.88
International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. J Med Genet (2009) 3.89
Mortality in systemic lupus erythematosus. Arthritis Rheum (2006) 3.61
The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. Q J Med (1993) 3.35
OBSERVATIONS ON THE FUNCTION OF PYRIDOXAL-5-PHOSPHATE IN PHOSPHORYLASE. Proc Natl Acad Sci U S A (1958) 3.07
Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate. Br Med J (Clin Res Ed) (1983) 2.63
Hotelling trace criterion and its correlation with human-observer performance. J Opt Soc Am A (1987) 2.46
Functional organelles in prokaryotes: polyhedral inclusions (carboxysomes) of Thiobacillus neapolitanus. Science (1973) 2.39
Enteroscopic diagnosis of small bowel ulceration in patients receiving non-steroidal anti-inflammatory drugs. Lancet (1991) 2.37
BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosus. Rheumatology (Oxford) (2005) 2.37
Polarity in the histidine operon. J Mol Biol (1966) 2.28
Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an international inception cohort study. Arthritis Rheum (2007) 2.18
Serum interleukin 6 levels in rheumatoid arthritis: correlations with clinical and laboratory indices of disease activity. Ann Rheum Dis (1993) 2.05
Is stenting following ureteroscopy for removal of distal ureteral calculi necessary? J Urol (1999) 2.04
Mitochondrial transfer ribonucleic acids. Proc Natl Acad Sci U S A (1967) 2.02
Illiteracy in rheumatoid arthritis patients as determined by the Rapid Estimate of Adult Literacy in Medicine (REALM) score. Rheumatology (Oxford) (2002) 2.00
An international cohort study of cancer in systemic lupus erythematosus. Arthritis Rheum (2005) 1.96
Mitochondrial-specific aminoacyl-RNA synthetases. Proc Natl Acad Sci U S A (1967) 1.90
What should we hope to achieve when treating rheumatoid arthritis? Ann Rheum Dis (1989) 1.89
Effect of disease modifying agents on the lipid profiles of patients with rheumatoid arthritis. Ann Rheum Dis (1997) 1.87
BSR/BHPR guideline for disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British Association of Dermatologists. Rheumatology (Oxford) (2006) 1.86
Atherosclerotic vascular events in a multinational inception cohort of systemic lupus erythematosus. Arthritis Care Res (Hoboken) (2010) 1.84
THE NEOPLASTIC POTENTIALITIES OF MOUSE EMBRYO TISSUES : I. THE FINDINGS WITH SKIN OF C STRAIN EMBRYOS TRANSPLANTED TO ADULT ANIMALS. J Exp Med (1945) 1.78
Lack of an alpha-1,4-glucan: alpha-1,4-glucan 6-glycosyl transferase in a case of type IV glycogenosis. Proc Natl Acad Sci U S A (1966) 1.72
Does second-line therapy affect the radiological progression of rheumatoid arthritis? Ann Rheum Dis (1984) 1.69
Shiga toxins induce, superinduce, and stabilize a variety of C-X-C chemokine mRNAs in intestinal epithelial cells, resulting in increased chemokine expression. Infect Immun (2001) 1.69
Accumulation of coronary artery disease risk factors over three years: data from an international inception cohort. Arthritis Rheum (2008) 1.65
Cardiovascular risk factors, including thrombotic variables, in a population with rheumatoid arthritis. Rheumatology (Oxford) (2001) 1.63
Nonsteroidal peptic damage in rheumatoid patients receiving second-line drugs. Am J Gastroenterol (1991) 1.57
Sulphasalazine for rheumatoid arthritis: toxicity in 774 patients monitored for one to 11 years. Br Med J (Clin Res Ed) (1986) 1.55
THE ENZYMATIC SYNTHESIS IN VITRO OF HYALURONIC ACID CHAINS. Proc Natl Acad Sci U S A (1955) 1.54
Which component of sulphasalazine is active in rheumatoid arthritis? Br Med J (Clin Res Ed) (1985) 1.51
A rheumatological dilemma: is it possible to modify the course of rheumatoid arthritis? Can we answer the question? Ann Rheum Dis (1985) 1.50
Thiopurine methyltransferase genotype predicts therapy-limiting severe toxicity from azathioprine. Ann Intern Med (1998) 1.50
Effect of acetylator phenotype on efficacy and toxicity of sulphasalazine in rheumatoid arthritis. Ann Rheum Dis (1985) 1.49
Studies of lysosomal alpha-glucosidase. I. Purification and properties of the rat liver enzyme. Biochemistry (1970) 1.49
Penetrating and blunt neck trauma: 10-year review of a Canadian experience. Can J Surg (1997) 1.46
Variations among rheumatologists in prescribing and monitoring of disease modifying antirheumatoid drugs. Br J Rheumatol (1992) 1.43
The 'natural' history of active rheumatoid arthritis over 3-6 months--an analysis of patients enrolled into trials of potential disease-modifying anti-rheumatic drugs, and treated with placebo. Br J Rheumatol (1993) 1.42
[Laser-induced Interstitial thermotherapy (LITT) in hepatic metastases of various sizes in an animal model]. Rofo (2005) 1.42
Antineutrophil cytoplasmic antibody titres in patients with recent infection. Br J Rheumatol (1993) 1.42
A case of orbital myositis associated with rheumatoid arthritis. Ann Rheum Dis (2002) 1.40
Methotrexate toxicity induced by acute renal failure. J R Soc Med (2004) 1.39
Control of Gastric Hyperacidity in Peptic Ulcer. Br Med J (1941) 1.39
Airway control during percutaneous tracheotomy. Laryngoscope (1994) 1.39
Isolation of Intact Chloroplasts from Euglena gracilis by Zonal Centrifugation. Plant Physiol (1971) 1.38
Complement-mediated inhibition of immune precipitation in patients with immune complex diseases. Clin Exp Immunol (1983) 1.38
Predictive value of interleukin 1 gene polymorphisms for surgery. Ann Rheum Dis (2000) 1.38
The clinicopathology of retinoblastoma. Am J Ophthalmol (1966) 1.37
Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis: results from an international inception cohort study. Arthritis Rheum (2008) 1.34
The use of the Internet as a resource for health information among patients attending a rheumatology clinic. Rheumatology (Oxford) (2002) 1.33
Sulphasalazine: a 'new' antirheumatic drug. Br J Rheumatol (1984) 1.30
Sulphasalazine in the treatment of rheumatoid arthritis: relationship of dose and serum levels to efficacy. Br J Rheumatol (1985) 1.30
Effect of sulphasalazine on the radiological progression of rheumatoid arthritis. Ann Rheum Dis (1987) 1.29
The subcellular distribution of enzymes in type II glycogenosis and the occurrence of an oligo-alpha-1,4-glucan glucohydrolase in human tissues. Biochim Biophys Acta (1965) 1.29
Tests for carcinogenicity of asbestos. Ann N Y Acad Sci (1965) 1.28
Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus. Ann Rheum Dis (2009) 1.27
Metal biomonitoring with mosses: procedures for correcting for soil contamination. Environ Pollut (1995) 1.26
Evolution of incipient nephropathy in type 2 diabetes mellitus. Kidney Int (2000) 1.26
Triple therapy in early active rheumatoid arthritis: a randomized, single-blind, controlled trial comparing step-up and parallel treatment strategies. Arthritis Rheum (2008) 1.24
Antioxidant effects of angiotensin-converting enzyme (ACE) inhibitors: free radical and oxidant scavenging are sulfhydryl dependent, but lipid peroxidation is inhibited by both sulfhydryl- and nonsulfhydryl-containing ACE inhibitors. J Cardiovasc Pharmacol (1992) 1.24
Simultaneous absence of alpha-1,4-glucosidase and alpha-1,6-glucosidase activities (pH 4) in tissues of children with type II glycogen storage disease. Biochemistry (1970) 1.22
Effect of an automated bedside dispensing machine on medication errors. Am J Hosp Pharm (1984) 1.21
Determination of gold in blood fractions by atomic-absorption spectrometry using carbon rod and carbon furnace atomisation. Analyst (1976) 1.21
A double blind, randomised, multicentre comparison of two doses of intravenous iloprost in the treatment of Raynaud's phenomenon secondary to connective tissue diseases. Ann Rheum Dis (1991) 1.20
Age-related changes in beta-adrenergic neuroeffector systems in the human heart. Circulation (1994) 1.20
A comparison of a short half-life marker (low-dose isoniazid), a long half-life pharmacological indicator (low-dose phenobarbitone) and measurements of a controlled release 'therapeutic drug' (metoprolol, Metoros) in reflecting incomplete compliance by volunteers. Br J Clin Pharmacol (1990) 1.19
Clinical and laboratory studies of levamisole in patients with rheumatoid arthritis. Q J Med (1978) 1.19
Non-Hodgkin's lymphoma in systemic lupus erythematosus. Ann Rheum Dis (2005) 1.19
Domains of the catalytically self-sufficient cytochrome P-450 BM-3. Genetic construction, overexpression, purification and spectroscopic characterization. Biochem J (1992) 1.19
N-desmethylclobazam: a possible alternative to clobazam in the treatment of refractory epilepsy? Br J Clin Pharmacol (1987) 1.18
Plasma zinc and its relationship to clinical symptoms and drug treatment in rheumatoid arthritis. Ann Rheum Dis (1980) 1.18
Captopril: a free radical scavenger. Br J Clin Pharmacol (1989) 1.16
Studies of lysosomal alpha-glucosidase. II. Kinetics of action of the rat liver enzyme. Biochemistry (1970) 1.15
Evidence of oxidative stress in chronic heart failure in humans. Eur Heart J (1993) 1.14
ACTION OF AMYLO-1,6-GLUCOSIDASE ON LOW MOLECULAR WEIGHT SUBSTRATES AND THE ASSAY OF THIS ENZYME IN GLYCOGEN STORAGE DISEASE. Proc Natl Acad Sci U S A (1962) 1.14
Continued use of non-steroidal anti-inflammatory drugs: an index of clinical efficacy. Br J Clin Pharmacol (1978) 1.14
Effect of social deprivation on disease severity and outcome in patients with rheumatoid arthritis. Ann Rheum Dis (1997) 1.13
Free radical pathology in chronic arterial disease. Free Radic Biol Med (1989) 1.13
Evaluation of 3-methylcrotonyl-CoA carboxylase deficiency detected by tandem mass spectrometry newborn screening. J Inherit Metab Dis (2003) 1.13
Preparation and properties of the glycogen-debranching enzyme from rabbit liver. Biochim Biophys Acta (1972) 1.13
Antiinflammatory effects of some copper complexes. J Med Chem (1980) 1.11
Comparison of computer-assisted instruction and seminar instruction to acquire psychomotor and cognitive knowledge of epistaxis management. Otolaryngol Head Neck Surg (1999) 1.11
Rheumatoid arthritis and macrovascular disease. Rheumatology (Oxford) (2003) 1.11
Ring chromosome X in a child with manifestations of Kabuki syndrome. Am J Med Genet (1997) 1.10
Burns because of epilepsy. Br Med J (Clin Res Ed) (1988) 1.10
Does social disadvantage contribute to the excess mortality in rheumatoid arthritis patients? Ann Rheum Dis (1999) 1.09
Decreased C3b receptors (CR1) on erythrocytes from patients with systemic lupus erythematosus. Clin Exp Immunol (1986) 1.09